1-20 of 80
Abhinav Deol
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 1 Study of SC291, a Hypoimmune, Allogeneic CD19-Directed CAR T Cell Therapy for Relapsed/Refractory B-Cell Malignancies (ARDENT) - Initial Clinical Data

Sattva S. Neelapu, L. Elizabeth Budde, Joseph P McGuirk, Saurabh Dahiya, Abhinav Deol, Philip A. Thompson, Nitin Jain, Matthew A Lunning, Xiaomeng Hu, Boris Gorovits, Danielle Quarles, Barbara Metallo, Meghan Flaherty, Weidong Zhang, Hosein Kouros-Mehr, Terry J. Fry, Sonja Schrepfer
Journal: Blood
Blood (2023) 142 (Supplement 1): 6852.
https://doi.org/10.1182/blood-2023-179441
Published: 2023
Journal Articles

Acute Leukemia and MDS Patients Older Than 70 Years Have Inferior Survival Following Allogeneic Stem Cell Transplant Compared to Those with 60-69 Years of Age

Asmita Shukla, Seongho Kim, Hyejeong Jang, Andrew Kin, Aasiya Matin, Lois Ayash, Abhinav Deol, Voravit Ratanatharathorn, Joseph Uberti, Dipenkumar Modi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3612.
https://doi.org/10.1182/blood-2023-190562
Published: 2023
Journal Articles

Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation

Nirali N. Shah, Jacques Azzi, Brenda W Cooper, Abhinav Deol, John DiPersio, Divya Koura, Brian McClune, Lori S. Muffly, Muhammad Umair Mushtaq, Rupa Narayan, Hyung Chan Suh, Gregory Yanik, Sritama Nath, Jennifer Whangbo, Guenther Koehne
Journal: Blood
Blood (2023) 142 (Supplement 1): 4862.
https://doi.org/10.1182/blood-2023-180990
Published: 2023
Journal Articles

Five Year Outcomes of Patients with Large B-Cell Lymphoma Treated with Standard-of-Care Axicabtagene Ciloleucel: Results from the US Lymphoma CAR-T Cell Consortium

Jay Y. Spiegel, Michael D. Jain, Loretta J. Nastoupil, John Tamaresis, Armin Ghobadi, Yi Lin, Lazaros J. Lekakis, Patrick M. Reagan, Olalekan O. Oluwole, Joseph P McGuirk, Abhinav Deol, Kathleen Dorritie, Alison R Sehgal, Andre Goy, Brian T. Hill, Charalambos Andreadis, Javier L. Munoz, Matthew L. Ulrickson, Jason Westin, Julio C. Chavez, Dilan A Patel, Miriam T. Jacobs, Radhika Bansal, N. Nora Bennani, Vivek Patel, Aaron P. Rapoport, Julie M. Vose, David B. Miklos, Sattva S. Neelapu, Frederick L. Locke, Matthew A Lunning, Saurabh Dahiya
Journal: Blood
Blood (2023) 142 (Supplement 1): 1032.
https://doi.org/10.1182/blood-2023-179868
Published: 2023
Journal Articles

The Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit the Growth of MLL-r AML

Md. Hafiz Uddin, Amro Aboukameel, Sharif hasan Siddiqui, Husain Khan, Sahar Bannoura, Abhinav Deol, Jay Yang, Gregory Dyson, Asfar Azmi, Lisa Polin, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2023) 142 (Supplement 1): 4168.
https://doi.org/10.1182/blood-2023-190638
Published: 2023
Journal Articles

Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma

Clinical Trials & Observations
Sattva S. Neelapu, Caron A. Jacobson, Armin Ghobadi, David B. Miklos, Lazaros J. Lekakis, Olalekan O. Oluwole, Yi Lin, Ira Braunschweig, Brian T. Hill, John M. Timmerman, Abhinav Deol, Patrick M. Reagan, Patrick Stiff, Ian W. Flinn, Umar Farooq, Andre H. Goy, Peter A. McSweeney, Javier Munoz, Tanya Siddiqi, Julio C. Chavez, Alex F. Herrera, Nancy L. Bartlett, Adrian A. Bot, Rhine R. Shen, Jinghui Dong, Kanwarjit Singh, Harry Miao, Jenny J. Kim, Yan Zheng, Frederick L. Locke
Journal: Blood
Blood (2023) 141 (19): 2307–2315.
https://doi.org/10.1182/blood.2022018893
Published: 2023
Includes: Supplemental data
Journal Articles

Does Choice of Salvage Regimen Impact Stem Cell Mobilization in Hodgkin's Lymphoma?

Abdul Moiz Khan, Neha Venkatesh, Joseph P. Uberti, Voravit Ratanatharathorn, Dipenkumar Modi, Lois Ayash, Asif Alavi, Andrew Kin, Aasiya Matin, Abhinav Deol
Journal: Blood
Blood (2022) 140 (Supplement 1): 7565–7566.
https://doi.org/10.1182/blood-2022-164618
Published: 2022
Journal Articles

Patient-Reported Outcomes in Long-Term Survivors of Autologous Hematopoietic Cell Transplantation for Hodgkin and Non-Hodgkin Lymphoma: Secondary Analysis from Two Multi-Center Randomized Controlled Trials of Hematopoietic Cell Transplant Survivorship Interventions

Agrima Mian, Wei Wei, Rajshekhar Chakraborty, Jean C. Yi, Jaime M. Preussler, Brian T. Hill, Jan Cerny, Abhinav Deol, Theresa E. Hahn, Shahrukh K. Hashmi, Samantha Jaglowski, Heather S.L. Jim, Nandita Khera, Alison W. Loren, Joseph P. McGuirk, Bipin N. Savani, Patrick Stiff, Joseph P. Uberti, Victoria Whalen, John R. Wingard, Jana Reynolds, Shernan G Holtan, William A. Wood, K. Scott Baker, Karen L. Syrjala, Betty K. Hamilton, Navneet S. Majhail
Journal: Blood
Blood (2022) 140 (Supplement 1): 8019–8021.
https://doi.org/10.1182/blood-2022-167411
Published: 2022
Journal Articles

Novel Combination of Clinical Menin Inhibitor Ziftomenib and the Nuclear Export Inhibitor Selinexor Synergistically Inhibit MLL-r AML

Md. Hafiz Uddin, Amro Aboukameel, Husain Khan, Sahar Bannoura, Yiwei Li, Abhinav Deol, Jay Yang, Asfar Sohail Azmi, Jaroslaw P. Maciejewski, Suresh Kumar Balasubramanian
Journal: Blood
Blood (2022) 140 (Supplement 1): 8811–8812.
https://doi.org/10.1182/blood-2022-168151
Published: 2022
Journal Articles

HLA-Haploidentical Vs Mismatched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis for AML and MDS: Is There a Winner?

Dipenkumar Modi, Maya Shatta, Seongho Kim, Abhinav Deol, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti
Journal: Blood
Blood (2022) 140 (Supplement 1): 694–695.
https://doi.org/10.1182/blood-2022-166536
Published: 2022
Journal Articles

Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): 2-Year Follow-up of ZUMA-1 Cohort 6

Olalekan O. Oluwole, Edouard Forcade, Javier Muñoz, Sophie de Guibert, Julie M. Vose, Nancy L. Bartlett, Yi Lin, Abhinav Deol, Peter A. McSweeney, Andre H. Goy, Marie José Kersten, Caron A. Jacobson, Umar Farooq, Monique C. Minnema, Catherine Thieblemont, John Timmerman, Patrick Stiff, Irit Avivi, Dimitrios Tzachanis, Yan Zheng, Saran Vardhanabhuti, Jenny Nater, Rhine R. Shen, Harry Miao, Jenny Kim, Tom van Meerten
Journal: Blood
Blood (2022) 140 (Supplement 1): 10399–10401.
https://doi.org/10.1182/blood-2022-156117
Published: 2022
Journal Articles

Effective Cell Dose and Functional Attributes of Azercabtagene Zapreleucel (azer-cel; PBCAR0191) Associate with Allogeneic CAR T-Cell Safety and Efficacy in Patients with Relapsed/Refractory B-Cell Lymphoma

Caron A. Jacobson, Tilanthi Jayawardena, Lou Yu, Jason Hallman, Robert Schmittling, Erin Cuneo, Ian Belle, Gavin Sampey, Danica Cabral, Ashleigh Derrick, Josie Tueller, Koen Van Besien, Scott R. Solomon, Adam J. Olszewski, Joseph E. Maakaron, Ran Reshef, Anthony S. Stein, Abhinav Deol, Nitin Jain, Alan F. List, Bijal D. Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 4588–4589.
https://doi.org/10.1182/blood-2022-165311
Published: 2022
Journal Articles

Incidence, Risk Factors and Outcomes of Pancytopenia Following Chimeric Antigen Receptor (CAR)-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma

Malini Surapaneni, Samer Alkassis, Seongho Kim, Abhinav Deol, Lois Ayash, Asif Alavi, Andrew Kin, Voravit Ratanatharathorn, Joseph P. Uberti, Dipenkumar Modi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4812.
https://doi.org/10.1182/blood-2021-148961
Published: 2021
Journal Articles

Feasibility of Outpatient CAR T Cell Therapy: Experience of a Single Institution

Yusra F Shao, Dipenkumar Modi, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Joseph P. Uberti, Abhinav Deol
Journal: Blood
Blood (2021) 138 (Supplement 1): 4828.
https://doi.org/10.1182/blood-2021-146283
Published: 2021
Journal Articles

Outcome of Severe Aplastic Anemia Post Allogenic Stem Cell Transplant with Mycophenolate and Calcineurin Inhibitor for Graft Versus Host Disease Prophylaxis

Omar Albanyan, Hyejeong Jang, Seongho Kim, Andrew Kin, Asif Alavi, Lois Ayash, Voravit Ratanatharathorn, Dipenkumar Modi, Joseph P. Uberti, Abhinav Deol
Journal: Blood
Blood (2021) 138 (Supplement 1): 4879.
https://doi.org/10.1182/blood-2021-144995
Published: 2021
Journal Articles

Updated Results from CARTITUDE-1: Phase 1b/2Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Patients With Relapsed/Refractory Multiple Myeloma

Thomas Martin, Saad Z. Usmani, Jesús G. Berdeja, Andrzej Jakubowiak, Mounzer Agha, Adam D Cohen, Parameswaran Hari, David Avigan, Abhinav Deol, Myo Htut, Alexander Lesokhin, Nikhil C. Munshi, Elizabeth O'Donnell, A. Keith Stewart, Jordan M. Schecter, Jenna D. Goldberg, Carolyn C. Jackson, Tzu-Min Yeh, Arnob Banerjee, Alicia Allred, Enrique Zudaire, William Deraedt, Deepu Madduri, Yunsi Olyslager, Changwei Zhou, Lida Pacaud, Yi Lin, Sundar Jagannath
Journal: Blood
Blood (2021) 138 (Supplement 1): 549.
https://doi.org/10.1182/blood-2021-146060
Published: 2021
Journal Articles

Allogeneic CAR-T PBCAR0191 with Intensified Lymphodepletion Is Highly Active in Patients with Relapsed/Refractory B-Cell Malignancies

Bijal D. Shah, Caron Jacobson, Scott R. Solomon, Nitin Jain, Mark C. Johnson, Monika Vainorius, Lou Yu, Christopher R. Heery, Alan F. List, Fiona He, Ran Reshef, Luke P. Akard, Craig S. Sauter, Adam J. Olszewski, Abhinav Deol, Koen van Besien
Journal: Blood
Blood (2021) 138 (Supplement 1): 302.
https://doi.org/10.1182/blood-2021-150609
Published: 2021
Journal Articles

Prophylactic Corticosteroid Use with Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): One-Year Follow-up of ZUMA-1 Cohort 6 (C6)

Olalekan O. Oluwole, Edouard Forcade, Javier Muñoz, Sophie de Guibert, Julie M. Vose, Nancy L. Bartlett, Yi Lin, Abhinav Deol, Peter A. McSweeney, Andre H. Goy, Marie José Kersten, Caron Jacobson, Umar Farooq, Monique C. Minnema, Catherine Thieblemont, John M. Timmerman, Patrick Stiff, Irit Avivi, Dimitrios Tzachanis, Jenny J. Kim, Yan Zheng, Rhine R. Shen, Saran Vardhanabhuti, Tom Van Meerten
Journal: Blood
Blood (2021) 138 (Supplement 1): 2832.
https://doi.org/10.1182/blood-2021-147403
Published: 2021
Journal Articles

Clinical Trials of BCMA-Targeted CAR-T Cells Utilizing a Novel Non-Viral Transposon System

Caitlin Costello, Ben A Derman, Mehmet Hakan Kocoglu, Abhinav Deol, Abbas Abbas Ali, Tara Gregory, Bhagirathbhai Dholaria, Jesus G Berdeja, Adam D Cohen, Krina K. Patel, David S. Siegel, Rajneesh Nath, Katherine McArthur, Joanne McCaigue, Christopher E Martin, Majid Ghoddusi, Hamid Namini, Eric M. Ostertag, Matthew A. Spear, Rajesh Belani, Nina Shah
Journal: Blood
Blood (2021) 138 (Supplement 1): 3858.
https://doi.org/10.1182/blood-2021-151672
Published: 2021
Journal Articles

Epidemiology and Predictors of Readmission in CAR T-Cell Therapy Recipients

Aditi Sharma, Vijendra Singh, Abhinav Deol
Journal: Blood
Blood (2021) 138 (Supplement 1): 3010.
https://doi.org/10.1182/blood-2021-153153
Published: 2021